CK
GSK icon

Carnick & Kubik’s GSK GSK Stock Holding History

Carnick & Kubik’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$26K Buy
+520
New +$25.9K 0.01% 749
2015
Q4 		– Sell
-520
Closed -$25K – 197
2015
Q3 		$25K Buy
+520
New +$27.1K 0.02% 252

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Carnick & Kubik's GSK Position: Q1 2016 in Review

Carnick & Kubik opened a new position in GSK (GSK) in Q1 2016: 520 shares worth $26K. The stake represents 0.01% of the portfolio and ranks #749 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in GSK as recently as Q3 2015.

Carnick & Kubik first reported a position in GSK in Q3 2015 and has held it in 2 quarters since. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Carnick & Kubik held 520 shares of GSK worth $26K as of Q1 2016.
  • GSK was a new Carnick & Kubik position in Q1 2016.
  • GSK made up 0.01% of Carnick & Kubik's portfolio in Q1 2016, its #749 holding.
  • Carnick & Kubik first reported a position in GSK in Q3 2015 and has held it in 2 quarters since.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.